Oragenics (OGEN) Announces 1-for-30 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
May 28, 2025 7:00 AM EDTSARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (Oragenics or the Company), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Directors (the Board) on May 27, 2025 approved a One-for-Thirty (1-for-30) reverse stock split of the Companys issued and outstanding shares of common stock, par value $0.001 per share (the Reverse Stock Split). As a result of the Reverse Stock Split, the Companys common stock is expected to begin trading on a split-adjusted basis when the markets open on June 3, 2025.
... More